[Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]. / Variables clínicas y farmacológicas de pacientes nonagenarios hospitalizados por COVID-19.
Rev Esp Quimioter
; 34(2): 145-150, 2021 Apr.
Article
in Spanish
| MEDLINE | ID: covidwho-1058742
ABSTRACT
OBJECTIVE:
Despite the impact of SARS-CoV-2 infection in geriatrics, data on nonagenarian patients is scarce. The aim of this study is to describe the clinical features of COVID19-diagnosed nonagenarians, as well as its clinical evolution and therapeutic response.METHODS:
Retrospective observational study of nonagenarians, admitted for COVID-19. Sociodemographic and clinical variables were registered, including previous polypharmacy. Blood analysis data and COVID-19-specific treatment were registered.RESULTS:
A total of 79 patients were included, with 50.6% (40 patients) of mortality. None of the comorbidities registered correlated with mortality, which was significantly higher among patients with moderate/complete functional dependence, compared to those mild-dependents/independents (59.5% vs 40.5%; p=0.015). Most prescribed drugs were hydroxychloroquine/chloroquine and azithromycin. Non-survivors presented higher counts of leukocytes and neutrophils, and higher lymphopenia.CONCLUSIONS:
Nonagenarians with functional dependence presented higher mortality, irrespective of comorbidities or treatment received. Implementing an integral geriatric evaluation would enhance the implementation of personalized therapeutic strategies for nonagenarians.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Aged, 80 and over
/
COVID-19
/
COVID-19 Drug Treatment
/
Hospitalization
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev Esp Quimioter
Journal subject:
Drug Therapy
Year:
2021
Document Type:
Article
Affiliation country:
Req
Similar
MEDLINE
...
LILACS
LIS